- Raised funding round, Jul 2017
About
FUSMobile advances noninvasive solutions for chronic painful conditions in order to improve the patient experience and clinical outcomes while reducing costs for healthcare providers and payers. The companys Neurolyser is a focused ultrasound treatment platform designed to relieve the suffering caused by a range of common conditions, including chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases. The completely noninvasive solution thermally ablates nerves without the risks, pain, high costs, and extensive training required by more invasive methods. FUSMobiles Neurolyser XR focused ultrasound device has finished its first-in-human study with excellent results and will soon enter pivotal clinical trials in pursuit of North American regulatory approval for facet joint arthritis, the first of many pain-related indications with potential benefits over currently available interventional pain treatments.
Funding history · 1 round · — total
Q&A
- What is FUSMobile's primary focus?
- FUSMobile focuses on advancing noninvasive solutions for chronic painful conditions, aiming to improve patient experience and clinical outcomes while reducing costs for healthcare providers and payers.
- What is FUSMobile's flagship product?
- FUSMobile's flagship product is the Neurolyser, a focused ultrasound treatment platform designed to relieve suffering from conditions such as chronic lower back (facet joint) pain, knee and hip arthritis, sacroiliitis, and bone metastases.
- What is the current development stage of FUSMobile's Neurolyser XR device?
- FUSMobile's Neurolyser XR focused ultrasound device has completed its first-in-human study with positive results and is preparing to enter pivotal clinical trials for North American regulatory approval for facet joint arthritis.
- When was FUSMobile founded?
- FUSMobile was founded in January 2014.
- How many employees does FUSMobile have?
- FUSMobile has 11-50 employees.
- Where is FUSMobile's headquarters located?
- FUSMobile's headquarters is located in Haifa, Israel.
- Which investor participated in FUSMobile's funding round in July 2017?
- OrbiMed participated in FUSMobile's funding round in July 2017.
- What is FUSMobile's primary sector?
- FUSMobile's primary sector is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fusmobile.com |
|---|---|
| linkedin.com/company/7603055 |
Identifiers & details
| Founded | 2014-1 |
|---|---|
| Employees (exact) | 17 |
| Offices | Alpharetta |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 5 |
|---|
Web history (Wayback)
| Domain | fusmobile.com |
|---|